Related by context. Frequent words. (Click for all words.) 57 Panzem R 55 OFIRMEV 55 RXi Pharmaceutical Corporation 54 Stedivaze 54 Eligard R 54 Genitope Corporation 53 MOZOBIL 53 vernakalant oral 53 PREOS 53 alvimopan 53 oral calcitonin 53 TOCOSOL Paclitaxel 53 KRYSTEXXA 53 SANCTURA R 52 Omigard 52 VANTAS 52 Plenaxis R 52 Topical Interferon Alpha 2b 52 6R BH4 52 Oxandrin 51 Celator 51 Entereg R 51 NUEDEXTA 51 Exelbine 51 reflect Sentry Select 51 ZYFLO CR 51 squalamine 51 Anturol 50 autoimmune indications 50 Bicifadine 50 MGCD# [001] 50 ZYFLO 50 talactoferrin 50 ZEGERID Powder 50 SILENOR TM 50 Phase IIa clinical trials 50 IND enabling 50 Acetavance 49 BrachySil 49 FavId 49 Rotarix R 49 www.patheon.com 49 CompanyaEUR TM s 49 confirmatory Phase III 49 elotuzumab 49 GLUMETZA 48 refractory Hodgkin lymphoma 48 PMA submission 48 Fibrillex TM 48 Fortical 48 celgosivir 48 Asentar 48 risks anduncertainties 48 TELCYTA 48 dirucotide 48 MONOVISC 48 forodesine 48 InKine 48 tivozanib 48 Genaera 47 Zanaflex Capsules 47 Protexia R 47 Anika Therapeutics 47 clinical trials 47 R sorafenib tablets 47 PLAVIX R 47 preclinical toxicology 47 orthobiologic 47 omecamtiv mecarbil 46 Allovectin 7 R 46 commercialization 46 MGCD# MGCD# [002] 46 non alcoholic steatohepatitis 46 SYMLIN 46 StratoComm Corporation 45 successfully commercialize 45 Hycroft Mine 45 AZASITE 45 ZEGERID 45 CUBICIN 45 NEUMUNE 45 phase IIb clinical 45 Interpharm 45 Nortel strategic alliances 45 obtaining regulatory approvals 44 preclinical 44 Strativa 44 Phenoptin 44 product introductions 44 RITUXAN 44 Phase Ib 44 www.norsat.com 44 refractory PTCL 44 suchforward looking 44 HGS ETR1 44 novel anticancer 44 preclinical studies 44 PXD# 44 Rosetta dependence 43 Glumetza 43 efficacy endpoints